GIOTRIF® :
The 1^st choice in 1^st-line

Superior efficacy vs gefitinib and vs chemotherapy
demonstrated in 3 large trials in 1^st-line EGFR M+ NSCLC^1-4*

First-line GIOTRIF® data in over 30 real-world studies to-date

Document ID: PC-MY-102816

03/02/2023

Author: Boehringer Ingelheim

123,000
Views

100k 340